Zanidatamab ELISA Kit

Zanidatamab is a novel her2-targeted antibody that binds two distinct extracellular domains of her2, allowing for multiple mechanisms of action including enhanced binding, clustering, receptor internalization and downregulation

The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.